Related Experiment Video
Updated: Jan 8, 2026

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
Neoadjuvant therapy in ovarian cancer: Emerging paradigms and therapeutic frontiers
Yuxuan Shi1, Xiong Wei2, Bairong Xia3
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230031, China.
Abstract:
The use of neoadjuvant therapy followed by intermittent tumor cytoreduction has emerged as an effective treatment for advanced ovarian cancer patients with high tumor load and poor physical status. Research on specific dosing regimens for neoadjuvant therapy has continued to gain momentum in recent years, involving the optimization of conventional chemotherapy regimens, the introduction of targeted agents and immunotherapies, and single-agent or multi-agent combination strategies. The purpose of this review is to provide a comprehensive review of these recent advances, with the aim of providing valuable references and bases for the clinical treatment of advanced ovarian cancer.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

